These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

421 related items for PubMed ID: 36773016

  • 1. Effectiveness and Accuracy of MRI-Ultrasound Fusion Targeted Biopsy Based on PI-RADS v2.1 Category in Transition/Peripheral Zone of the Prostate.
    Liu Y, Wang S, Xu G, Zhou B, Zhang Y, Ye B, Xiang L, Zhang Y, Xu H.
    J Magn Reson Imaging; 2023 Sep; 58(3):709-717. PubMed ID: 36773016
    [Abstract] [Full Text] [Related]

  • 2. [Diagnostic efficacy of prostate cancer using targeted biopsy with 6-core systematic biopsy for patients with PI-RADS 5].
    Liu Y, Yuan CW, Wu JY, Shen Q, Xiao JX, Zhao Z, Wang XY, Li XS, He ZS, Zhou LQ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct 18; 55(5):812-817. PubMed ID: 37807733
    [Abstract] [Full Text] [Related]

  • 3. Prevalence of Prostate Cancer in PI-RADS Version 2.1 Transition Zone Atypical Nodules Upgraded by Abnormal DWI: Correlation With MRI-Directed TRUS-Guided Targeted Biopsy.
    Lim CS, Abreu-Gomez J, Carrion I, Schieda N.
    AJR Am J Roentgenol; 2021 Mar 18; 216(3):683-690. PubMed ID: 32755208
    [Abstract] [Full Text] [Related]

  • 4. A clinical available decision support scheme for optimizing prostate biopsy based on mpMRI.
    Hou Y, Jiang KW, Zhang J, Bao ML, Shi HB, Qu JR, Cheng G, Zhang YD.
    Prostate Cancer Prostatic Dis; 2022 Apr 18; 25(4):727-734. PubMed ID: 35067674
    [Abstract] [Full Text] [Related]

  • 5. Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Kaufmann B, Saba K, Schmidli TS, Stutz S, Bissig L, Britschgi AJ, Schaeren E, Gu A, Langenegger N, Sulser T, Eberli D, Keller EX, Hermanns T, Poyet C.
    Prostate; 2022 Feb 18; 82(3):388-396. PubMed ID: 34914121
    [Abstract] [Full Text] [Related]

  • 6. Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy.
    Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, Raj G, Margulis V, Cadeddu JA, Lotan Y, Francis F, Pedrosa I, G Roehrborn C, Costa DN.
    Urol Oncol; 2019 Jan 18; 37(1):57-62. PubMed ID: 30446460
    [Abstract] [Full Text] [Related]

  • 7. Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer.
    Stabile A, Dell'Oglio P, Soligo M, De Cobelli F, Gandaglia G, Fossati N, Esposito A, Brembilla G, Karnes RJ, Montorsi F, Briganti A.
    Eur Urol Oncol; 2021 Aug 18; 4(4):594-600. PubMed ID: 31204312
    [Abstract] [Full Text] [Related]

  • 8. Prostate biopsy in the era of MRI-targeting: towards a judicious use of additional systematic biopsy.
    Deniffel D, Perlis N, Ghai S, Girgis S, Healy GM, Fleshner N, Hamilton R, Kulkarni G, Toi A, van der Kwast T, Zlotta A, Finelli A, Haider MA.
    Eur Radiol; 2022 Nov 18; 32(11):7544-7554. PubMed ID: 35507051
    [Abstract] [Full Text] [Related]

  • 9. Comparison of prostate cancer detection rates between magnetic resonance imaging-targeted biopsy and transrectal ultrasound-guided biopsy according to Prostate Imaging Reporting and Data System in patients with PSA ≥4 ng/mL: a systematic review and meta-analysis.
    Zhu K, Qin Z, Xue J, Miao C, Tian Y, Liu S, Zhu S, Gu Q, Hou C, Xu A, Yang J, Wang Z.
    Transl Androl Urol; 2019 Dec 18; 8(6):741-753. PubMed ID: 32038971
    [Abstract] [Full Text] [Related]

  • 10. Accuracy of elastic fusion biopsy: Comparing prostate cancer detection between targeted and systematic biopsy.
    Oderda M, Albisinni S, Benamran D, Calleris G, Ciccariello M, Dematteis A, Diamand R, Descotes JL, Fiard G, Forte V, Giacobbe A, Marquis A, Marra G, Messas A, Muto G, Peltier A, Rius L, Simone G, Roumeguere T, Faletti R, Gontero P.
    Prostate; 2023 Feb 18; 83(2):162-168. PubMed ID: 36259316
    [Abstract] [Full Text] [Related]

  • 11. Prospective PI-RADS v2.1 Atypical Benign Prostatic Hyperplasia Nodules With Marked Restricted Diffusion: Detection of Clinically Significant Prostate Cancer on Multiparametric MRI.
    Costa DN, Jia L, Subramanian N, Xi Y, Rofsky NM, Recchimuzzi DZ, de Leon AD, Arraj P, Pedrosa I.
    AJR Am J Roentgenol; 2021 Aug 18; 217(2):395-403. PubMed ID: 32876473
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy of multiparametric MRI- and microultrasound-targeted biopsy in biopsy-naïve patients with a PI-RADS 5 lesion: a single-institutional study.
    Avolio PP, Fasulo V, Sanchez-Salas R, Maffei D, Frego N, Lazzeri M, Paciotti M, Saita A, Hurle R, Guazzoni G, Casale P, Buffi NM, Lughezzani G.
    World J Urol; 2023 Sep 18; 41(9):2335-2342. PubMed ID: 37418017
    [Abstract] [Full Text] [Related]

  • 13. Detection of clinically significant prostate cancer by transperineal multiparametric magnetic resonance imaging-ultrasound fusion targeted prostate biopsy in smaller prostates.
    Dahl DM, Kim MM, Wu S, Lin SX, Crotty RK, Cornejo KM, Harisinghani MG, Feldman AS, Wu CL.
    Urol Oncol; 2022 Oct 18; 40(10):451.e9-451.e14. PubMed ID: 36008257
    [Abstract] [Full Text] [Related]

  • 14. Targeted Biopsy With Reduced Number of Cores: Optimal Sampling Scheme in Patients Undergoing Magnetic Resonance Imaging/Transrectal Ultrasound Fusion Prostate Biopsy.
    Shen WW, Cui LG, Ran WQ, Sun Y, Jiang J, Pei XL, Chen W.
    Ultrasound Med Biol; 2020 May 18; 46(5):1197-1207. PubMed ID: 32107089
    [Abstract] [Full Text] [Related]

  • 15. Using Prostate Imaging-Reporting and Data System (PI-RADS) Scores to Select an Optimal Prostate Biopsy Method: A Secondary Analysis of the Trio Study.
    Ahdoot M, Lebastchi AH, Long L, Wilbur AR, Gomella PT, Mehralivand S, Daneshvar MA, Yerram NK, O'Connor LP, Wang AZ, Gurram S, Bloom J, Siddiqui MM, Linehan WM, Merino M, Choyke PL, Pinsky P, Parnes H, Shih JH, Turkbey B, Wood BJ, Pinto PA, Trio Study Group.
    Eur Urol Oncol; 2022 Apr 18; 5(2):176-186. PubMed ID: 33846112
    [Abstract] [Full Text] [Related]

  • 16. Optimizing Combined Magnetic Resonance Imaging (MRI)-Targeted and Systematic Biopsy Strategies: Sparing the Multiparametric MRI-Negative Transitional Zone in Presence of Exclusively Peripheral Multiparametric MRI-Suspect Lesions.
    Kachanov M, Leyh-Bannurah SR, Roberts MJ, Sauer M, Beyersdorff D, Boiko S, Maurer T, Steuber T, Graefen M, Budäus L.
    J Urol; 2022 Feb 18; 207(2):333-340. PubMed ID: 34555925
    [Abstract] [Full Text] [Related]

  • 17. Adding systematic biopsy to magnetic resonance ultrasound fusion targeted biopsy of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized study.
    Porreca A, Del Giudice F, Giampaoli M, D'Agostino D, Romagnoli D, Corsi P, Del Rosso A, Maggi M, Chung BI, Ferro M, de Cobelli O, Lucarelli G, Schiavina R, De Berardinis E, Sciarra A, Busetto GM.
    Medicine (Baltimore); 2020 Sep 11; 99(37):e22059. PubMed ID: 32925739
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Does PSA level affect the choice of prostate puncture methods among MRI-ultrasound fusion targeted biopsy, transrectal ultrasound systematic biopsy or the combination of both?
    Liu Y, Dong L, Xiang L, Zhou B, Wang H, Zhang Y, Xu G, Wu J, Wang S, Zhang Y, Xu H.
    Br J Radiol; 2021 Jul 01; 94(1123):20210312. PubMed ID: 34133228
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.